Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

by Schlitt Hans J, Glockzin Gabriel, Piso Pompiliu
Published 2009-01-01

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer

by Loss Martin, Dahlke Marc-Hendrik, Piso Pompiliu, Schlitt Hans
Published 2004-06-01

A case of virilization induced by a Krukenberg tumor from gastric cancer

by Schlitt Hans-Jürgen, Schubert Thomas, Vogel Peter, Hornung Matthias, Bolder Ulrich
Published 2008-02-01

DX5⁺NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1^-Balb/c and NK1.1⁺C57Bl/6 mice

by Geissler Edward K, Schlitt Hans J, Farkas Stefan A, Busl Elisabeth, Werner Jens M, Hornung Matthias
Published 2011-04-01

Deletion of Foxp3⁺ regulatory T cells in genetically targeted mice supports development of intestinal inflammation

by Boehm Franziska, Martin Maria, Kesselring Rebecca, Schiechl Gabriela, Geissler Edward K, Schlitt Hans-Jürgen, Fichtner-Feigl Stefan
Published 2012-07-01

ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization <it>in vivo</it...

by Schlitt Hans J, Hellerbrand Claus, Mori Akira, Lang Sven A, Moser Christian, Geissler Edward K, Fogler William E, Stoeltzing Oliver
Published 2008-07-01

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC...

by Glockzin Gabriel, Rochon Justine, Arnold Dirk, Lang Sven A, Klebl Frank, Zeman Florian, Koller Michael, Schlitt Hans J, Piso Pompiliu
Published 2013-02-01

Study Protocol: A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal...

by Schnitzbauer Andreas A, Scherer Marcus N, Rochon Justine, Sothmann Johannes, Farkas Stefan A, Loss Martin, Geissler Edward K, Obed Aiman, Schlitt Hans J
Published 2010-09-01

Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition

by Dietmeier Wolfgang, Hellerbrand Claus, Fichtner-Feigl Stefan, Mori Akira, Moser Christian, Lang Sven A, Hackl Christina, Schlitt Hans J, Geissler Edward K, Stoeltzing Oliver
Published 2010-12-01

ChroPac-Trial: Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. Trial protocol of a randomised controlled multicentre trial

by Schlitt Hans, Glanemann Matthias, Halloran Christopher, Contin Pietro, Bruckner Thomas, Diener Markus K, Mössner Joachim, Kieser Meinhard, Werner Jens, Büchler Markus W, Seiler Christoph M
Published 2010-04-01

Treatment with bevacizumab and FOLFOXIRI in patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and PERIMAX) and review of the literature

by Stein Alexander, Glockzin Gabriel, Wienke Andreas, Arnold Dirk, Edelmann Thomas, Hildebrandt Bert, Hollerbach Stephan, Illerhaus Gerald, Königsrainer Alfred, Richter Michael, Schlitt Hans J, Schmoll Hans-Joachim
Published 2012-08-01

A human ex vivo coculture model to investigate peritoneal metastasis and innovative treatment options

by Mönch Dina, Koch Jana, Maaß Annika, Janssen Nicole, Mürdter Thomas, Renner Philipp, Fallier-Becker Petra, Solaß Wiebke, Schwab Matthias, Dahlke Marc-H., Schlitt Hans J., Leibold Tobias
Published 2021-07-01

Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation

by Dillmann Johannes, Popp Felix C, Fillenberg Barbara, Zeman Florian, Eggenhofer Elke, Farkas Stefan, Scherer Marcus N, Koller Michael, Geissler Edward K, Deans Robert, Ladenheim Deborah, Loss Martin, Schlitt Hans J, Dahlke Marc H
Published 2012-11-01

Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)

by Popp Felix C, Fillenberg Barbara, Eggenhofer Elke, Renner Philipp, Dillmann Johannes, Benseler Volker, Schnitzbauer Andreas A, Hutchinson James, Deans Robert, Ladenheim Deborah, Graveen Cheryl A, Zeman Florian, Koller Michael, Hoogduijn Martin J, Geissler Edward K, Schlitt Hans J, Dahlke Marc H
Published 2011-07-01

A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocel...

by Roy Andre, Rostaing Lionel, Rossi Giorgio, Rizell Magnus, Pirenne Jacques, Pinna Antonio D, Pageaux Georges-Philippe, Otto Gerd, Mutzbauer Ingrid, Mazzaferro Vincenzo, Margreiter Raimund, Mäkisalo Heikki, Lerut Jan P, Lamby Philipp E, Königsrainer Alfred, Jamieson Neville, Hidalgo Ernest, Heise Michael, Hauss Johann P, Gugenheim Jean, Fändrich Fred, Colledan Michele, Cillo Umberto, Chazouillères Olivier, Beckebaum Susanne, Becker Thomas, Bechstein Wolf O, Adam Rene, Kneteman Norman M, Duvoux Christophe, de Jong Koert P, Burra Patrizia, Bilbao Itxarone, Rochon Justine, Graeb Christian, Zuelke Carl, Schnitzbauer Andreas A, Turrion Victor, Schmidt Jan, Troisi Roberto I, van Hoek Bart, Valente Umberto, Wolf Philippe, Wolters Heiner, Mirza Darius F, Scholz Tim, Steininger Rudolf, Soderdahl Gunnar, Strasser Simone I, Jauch Karl-Walter, Neuhaus Peter, Schlitt Hans J, Geissler Edward K
Published 2010-05-01